Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients

The rising prevalence of neurological conditions like stroke and multiple sclerosis (MS) has heightened the need for effective treatment options. The World Health Organization reports a 50% increase in the lifetime risk of stroke over the past 17 years, with close to 3 million people affected by MS worldwide. Current medications for these conditions have…

Read More

College Health Trinity College Dublin are seeking a GP

Trinity College Dublin is looking for a GP to work in the College Health Service, delivering medical care to students and staff. The role includes open access and fixed appointment surgery, as well as specialized clinics. The service also focuses on mental and occupational aspects of student health and education. The position is a specific…

Read More

Fitbit, Quest partner to study metabolic health using wearable data

Quest Diagnostics and Google’s Fitbit are partnering on a study called Wearables for Metabolic Health (WEAR-ME) to examine how wearable technology can improve metabolic health. The study will combine Fitbit’s data with health information from Quest Diagnostics’ lab tests to assess metabolic health and potentially prevent disease. Metabolic health is measured by five markers, and…

Read More

Biden Cracks Down on Prior Authorization — But There Are Limits

The Biden administration announced a final rule changing how insurers in federal programs like Medicare Advantage use prior authorization, which has long prevented many patients from accessing doctor-recommended care. The rule will require some insurers to adopt an electronic process for prior authorization and respond to requests within specified time frames. However, it only applies…

Read More

How digital therapeutics firms are pivoting after Pear’s bankruptcy

The traditional approach of selling digital therapeutics as prescription drugs has proven to be unsuccessful, as demonstrated by the bankruptcy of Pear Therapeutics. Despite receiving FDA clearance for its app treating substance use disorders and insomnia, Pear Therapeutics struggled to get insurers to cover their treatments. Sticking to their original plan ultimately cost the company…

Read More
error: Content is protected !!